Sanofi SA
PAR:SAN

Watchlist Manager
Sanofi SA Logo
Sanofi SA
PAR:SAN
Watchlist
Price: 89.52 EUR -0.71% Market Closed
Updated: May 26, 2024

Sanofi SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sanofi SA
Cost of Revenue Peer Comparison

Comparables:
IPN
VETO
VIRP
BOI
MEDCL

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sanofi SA
PAR:SAN
Cost of Revenue
-€21.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ipsen SA
PAR:IPN
Cost of Revenue
-€571.2m
CAGR 3-Years
-5%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
Vetoquinol SA
PAR:VETO
Cost of Revenue
-€205m
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-2%
Virbac SA
PAR:VIRP
Cost of Revenue
-€437.3m
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
-1%
Boiron SA
PAR:BOI
Cost of Revenue
-€135.2m
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
0%
Medincell SA
PAR:MEDCL
Cost of Revenue
-€3.4m
CAGR 3-Years
-52%
CAGR 5-Years
-38%
CAGR 10-Years
N/A

See Also

What is Sanofi SA's Cost of Revenue?
Cost of Revenue
-21.5B EUR

Based on the financial report for Mar 31, 2024, Sanofi SA's Cost of Revenue amounts to -21.5B EUR.

What is Sanofi SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-28%

Over the last year, the Cost of Revenue growth was -28%.